Skip to content
10-K

Annual Report

Elevance Health, Inc. ELV

0001156039-26-000013

← back to feed
Filed
Feb 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 1, 2026 220.7M sh
Shares Diluted FY 2025 · Dec 31, 2025 224.6M sh
Shares Diluted FY 2025 · Dec 31, 2024 232.9M sh
Shares Diluted FY 2025 · Dec 31, 2023 237.4M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $2.61B
Stock Repurchased FY 2025 · Dec 31, 2024 $2.9B
Stock Repurchased FY 2025 · Dec 31, 2023 $2.68B
Dividends Paid FY 2025 · Dec 31, 2025 $377M
Dividends Paid FY 2025 · Dec 31, 2025 $1.53B
Dividends Paid FY 2025 · Sep 30, 2025 $381M
Dividends Paid FY 2025 · Jun 30, 2025 $385M
Dividends Paid FY 2025 · Mar 31, 2025 $386M
Dividends Paid FY 2025 · Dec 31, 2024 $373M
Dividends Paid FY 2025 · Dec 31, 2024 $1.51B
Dividends Paid FY 2025 · Sep 30, 2024 $378M
Dividends Paid FY 2025 · Jun 30, 2024 $378M
Dividends Paid FY 2025 · Mar 31, 2024 $379M
Dividends Paid FY 2025 · Dec 31, 2023 $1.4B
Capex FY 2025 · Dec 31, 2025 $1.12B
Capex FY 2025 · Dec 31, 2024 $1.26B
Capex FY 2025 · Dec 31, 2023 $1.3B
Operating Cash Flow FY 2025 · Dec 31, 2025 $4.29B
Operating Cash Flow FY 2025 · Dec 31, 2024 $5.81B
Operating Cash Flow FY 2025 · Dec 31, 2023 $8.06B
Long Term Debt FY 2025 · Dec 31, 2025 $30.8B
Long Term Debt FY 2025 · Dec 31, 2024 $29.22B
Short Term Debt FY 2025 · Dec 31, 2025 $150M
Short Term Debt FY 2025 · Dec 31, 2024 $365M
Cash And Equivalents FY 2025 · Dec 31, 2025 $9.49B
Cash And Equivalents FY 2025 · Dec 31, 2024 $8.29B
Stockholders Equity FY 2025 · Dec 31, 2025 $43.88B
Stockholders Equity FY 2025 · Dec 31, 2024 $41.32B
Current Liabilities FY 2025 · Dec 31, 2025 $41.04B
Current Liabilities FY 2025 · Dec 31, 2024 $40.58B
Total Liabilities FY 2025 · Dec 31, 2025 $77.47B
Total Liabilities FY 2025 · Dec 31, 2024 $75.46B
Current Assets FY 2025 · Dec 31, 2025 $63B
Current Assets FY 2025 · Dec 31, 2024 $58.94B
Total Assets FY 2025 · Dec 31, 2025 $121.49B
Total Assets FY 2025 · Dec 31, 2024 $116.89B
Eps Diluted FY 2025 · Dec 31, 2025 $25.21
Eps Diluted FY 2025 · Dec 31, 2024 $25.68
Eps Diluted FY 2025 · Dec 31, 2023 $25.22
Eps Basic FY 2025 · Dec 31, 2025 $25.28
Eps Basic FY 2025 · Dec 31, 2024 $25.81
Eps Basic FY 2025 · Dec 31, 2023 $25.38
Sga Expense FY 2025 · Dec 31, 2025 $20.98B
Sga Expense FY 2025 · Dec 31, 2024 $20.03B
Sga Expense FY 2025 · Dec 31, 2023 $20.09B
Net Income FY 2025 · Dec 31, 2025 $5.66B
Net Income FY 2025 · Dec 31, 2024 $5.98B
Net Income FY 2025 · Dec 31, 2023 $5.99B
Operating Income FY 2025 · Dec 31, 2025 $7.2B
Operating Income FY 2025 · Dec 31, 2024 $7.86B
Operating Income FY 2025 · Dec 31, 2023 $8.5B
Cost Of Revenue FY 2025 · Dec 31, 2025 $21.18B
Cost Of Revenue FY 2025 · Dec 31, 2024 $19.75B
Cost Of Revenue FY 2025 · Dec 31, 2023 $17.29B
Revenue FY 2025 · Dec 31, 2025 $199.13B
Revenue FY 2025 · Dec 31, 2024 $177.01B
Revenue FY 2025 · Dec 31, 2023 $171.34B